eCite Digital Repository

A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC)

Citation

Igleslas, J and Cromble, C and Burns, WI and Karapetis, C and Lowenthal, RM and Kirsten, F and Davidson, JA and Abell, F and Reece, WHH and DeSouza, P, A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC), European Journal of Cancer Abstracts, 21-25 September 2003, Copenhagen, Denmark, pp. S235. (2003) [Conference Extract]

Item Details

Item Type:Conference Extract
Research Division:Biomedical and Clinical Sciences
Research Group:Oncology and carcinogenesis
Research Field:Oncology and carcinogenesis not elsewhere classified
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Lowenthal, RM (Professor Ray Lowenthal)
ID Code:27150
Year Published:2003
Deposited By:Medicine
Deposited On:2003-08-01
Last Modified:2004-01-06
Downloads:0

Repository Staff Only: item control page